Drug Information

Drug General Information
Drug ID
D0H2IO
Former ID
DNC001087
Drug Name
P32/98
Drug Type
Small molecular drug
Indication Autism [ICD9: 299; ICD10:F84.0] Phase 2 [535416]
Structure
Download
2D MOL

3D MOL
Formula
C13H22N2O5S
Canonical SMILES
CCC(C)C(C(=O)N1CCSC1)N.C(=CC(=O)O)C(=O)O
InChI
1S/C9H18N2OS.C4H4O4/c1-3-7(2)8(10)9(12)11-4-5-13-6-11;5-3(6)1-2-4(7)8/h7-8H,3-6,10H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t7-,8-;/m0./s1
InChIKey
ZSOPWZQRZHWYFY-NUXPJIRBSA-N
PubChem Compound ID
6918464
PubChem Substance ID
12015316, 14801319, 17194905, 43529834, 78235912, 114788012, 134340333
Target and Pathway
Target(s) Dipeptidyl peptidase IV Target Info Inhibitor [535416]
KEGG Pathway Protein digestion and absorption
NetPath Pathway IL2 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
References
Ref 535416Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats. Diabetes. 2002 Apr;51(4):943-50.
Ref 535416Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats. Diabetes. 2002 Apr;51(4):943-50.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.